International workshop on taking novel drugs from lab to clinic

New Delhi: The international non-profit organization Drugs for Neglected Diseases Initiative (DNDi), the Indian Society for Clinical Research (ISCR), and Venture Center’s BIRAC Regional Bio-Innovation Center (BRBC) will be conducting an international workshop on taking novel drugs from lab to clinic on March 07-11, 2022.

The workshop will be held virtually, and will bring together the world’s leading subject matter experts, scientists, and representatives from industry with diverse pharmaceutical experience to share insights on the path of translational research for small molecules.

Workshop participants can look forward to learning and understanding concepts and methods in drug development and translation from practical experiences and real-life case studies. The workshop brings together 28 national and international speakers from leading pharmaceutical companies such as Cipla, Johnson and Johnson, Dr. Reddy’s Laboratories, Bayer A G Pharmaceuticals, Syngene International, and reputed universities and research organizations such as THSTI, Faridabad, University of Dundee and Northeastern university.

The workshop will be conducted over 5 days, and will broadly cover topics such as successful lead optimization, pharmaceutical development, safety pharmacology, Toxicology, and first-in-human clinical trials. Speakers include: Dr. Kirandeep Samby from Medicines for Malaria Venture, Anirudh Gautam from Dr. Reddy’s Laboratories, Dr. Senthilkumar Mariappan from Bayer AG, Dr. Sumati Nambiar from Johnson and Johnson, Dr. Vivek Kumaravel from Syngene International, Ravinder Kodipyaka from Aurigene Pharmaceuticals, Dr. K.S. Rao from Eurofins Advinus, Dr. Benjamin Perry, Dr. Stephen
Robinson, Ms. Stephanie Braillard, and Dr Jean-Yves Gillon from DNDi. and more.

The event will also see participation from Dr. Jaideep Gogtay from Cipla, Dr. Nitin Shetty from Bioneeds India, Dr. Shridhar Narayanan from Foundation for Neglected Disease Research, Dr. Amit Antarkar from Mylan Laboratories.

Registrations close on March 3, 2022. Interested persons can click here for more information.

“While India has a fantastic track record in generic drug development/repurposing, novel process development and pharma manufacturing, the experience in piloting novel drugs from lab to market is relatively weaker due to limited number of case studies available. This international workshop focuses on knowledge sharing from global experts and practical insights from real-life case studies. Venture Center is happy to co-organize this workshop with the goal of building translation and innovation capacity in India,” stated the note by the organizers.